Valerie,
I found a research article that mentions Dennis Heuring, the managing
partner of Solus Products, LLC (see last sentence):
http://www.ajcn.org/cgi/content/full/77/5/1261
>>>Glycomacropeptide and alpha-lactalbumin supplementation of infant formula
affects growth and nutritional status in infant rhesus monkeys
Abstract
Background: Advances in dairy technology make it possible to enrich infant
formula with specific bovine milk components that may enhance nutrient
status. Glycomacropeptide, a carbohydrate-rich casein peptide, may increase
absorption of calcium, iron, or zinc. alpha-Lactalbumin, a major breast-milk
protein, may contribute to a balanced amino acid pattern and increase
calcium and zinc absorption.
Objective: We determined the effects of glycomacropeptide- and
alpha-lactalbumin-supplemented infant formula on growth; trace mineral
status; iron, zinc, and calcium absorption; and plasma amino acid, blood
urea nitrogen, and plasma insulin concentrations.
Design: Infant rhesus monkeys (n = 5 infants per group) were breastfed or
fed control or alpha-lactalbumin- or glycomacropeptide-supplemented formula
from birth to 4 mo of age. Hematologic measures and growth were assessed
monthly. Mineral absorption was measured with radioisotopes and whole body
counting.
Results: Infants fed glycomacropeptide had higher food intake than did other
formula-fed infants. Infants fed glycomacropeptide or control formula had
higher hematocrit values than did infants that were breastfed or fed
alpha-lactalbumin. Infants fed glycomacropeptide or control formula had
higher plasma zinc and zinc absorption than did breastfed infants. Where
differences were observed, breastfed infants and infants fed
alpha-lactalbumin had similar plasma essential amino acid and insulin
profiles, which were different from those of infants fed glycomacropeptide
or control formula.
Conclusions: Glycomacropeptide- or alpha-lactalbumin-supplemented formula
has no adverse effects on nutritional status in infant monkeys.
Glycomacropeptide supplementation increases zinc absorption, which may
permit the reduction of formula zinc concentrations, and alpha-lactalbumin
supplementation promotes a plasma amino acid pattern similar to that of
breastfed infant monkeys.<<<
[snip majority of article]
>>>In summary, supplementation of infant formula with glycomacropeptide or
alpha-lactalbumin does not appear to adversely affect the nutritional status
of growing infant rhesus monkeys. In fact, iron and copper status indicators
(hematocrit and plasma copper) were positively affected by the addition of
these specific milk protein
fractions. Furthermore, enhanced zinc absorption resulted from
supplementation of infant formula with these components. If similar results
are obtained in human infants, the formula industry may be able to reduce
the concentration of trace minerals in formula, thus protecting infants from
the potential adverse effects of excess dietary intake. In addition, infant
monkeys fed formula supplemented with alpha-lactalbumin had a plasma amino
acid profile similar to that of breastfed infant monkeys. If similar
observations are made in human infants, these changes may have positive
consequences, particularly if the trend continues toward a reduction in
protein concentration in infant formula.
We are grateful to Dennis Heuring for assistance in the formulation of the
experimental diets<<<
Pat W
-----Original Message-----
From: Lactation Information and Discussion
[mailto:[log in to unmask]]On Behalf Of Valerie W, McClain
Sent: Saturday, July 10, 2004 6:20 AM
To: [log in to unmask]
Subject: crafting infant formula regualtions
One of the companies that is listed belonging to the International Formula
Council (IFC) is Solus Products, LLC. Solus was confirming its endorsement
of
the comments submitted to the FDA by the IFC. No one as yet has given me
the
name of the infant formula that this company produces nor have I found
anything
in a web search. I did find a letter in the FDA dockets written by this
company on July 10, 2004 in regard to docket 95N-0309 regarding "good
manufacturing practice, quality control procedures, quality factors,
notification
requirements and records and reports, for the production of infant formula."
The
letter is very interesting. Let me just quote from the letter's last
sentence,
"We hope that this effort can be continued in dialogue with FDA in a joint
effort to craft final regulations that are clear, constructive, and
effective."
http://www.fda.gov/ohrms/dockets/dailys/03/Sept03/090503/95N-0309-emc-000004
-0
1.doc
Obviously, Solus Products, LLC (part of the International Formula Council)
believes that they are working jointly with the FDA to craft final
regulations
on infant formula. Wow, if true, kinda sends a shiver down your back. The
regulatory agency and the manufacturers get to make the regs together. I
think
this is a rather remarkable letter. The FDA is under the command of
Secretary
Tommy Thompson.
Valerie W. McClain, IBCLC
***********************************************
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
***********************************************
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
